Faculty List (alphabetical order)

Rudi Agius, MD Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Othman Al-Sawaf, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Mary Ann Anderson, MD Department of Medical Biology, The University of Melbourne, Melbourne, VIC, Australia

Stuart Blakemore, PhD Department I of Internal Medicine, Translational Research for Infectious Diseases and Oncology (TRIO), University Hospital Clinic of Cologne, Cologne, Germany

Gonzalo Blanco, PhD The Feinstein Institutes for Medical Research, Manhasset, United States

Christoph Brey, MD University Hospital Ulm, Internal Medicine III, Division of CLL, Ulm Germany

Jennifer Brown, MD, PhD Department of Medical Oncology, Dana Farber Cancer Institute, Boston, United States

Elena Camerini, Department of Experimental Immunology, Amsterdam UMC, Amsterdam, The Netherlands; Department of Hematology, Amsterdam UMC, Amsterdam, The Netherlands

Elias Campo, MD Department of Hematology, Hospital Clínic Villarroel n masculine 170, Barcelona, Spain

Martina Cardillo, PhD The Feinstein Institutes for Medical Research, Experimental Immunology, Manhasset, United States

Ruth Clifford, PhD Oxford Cancer and Haematology Centre, Oxford University Hospitals, Churchill Site, Oxford, United Kingdom

Adalgisa Condoluci, MD Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland

Paula Cramer, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Carolyne Croizier, Service de thérapie cellulaire et d'hématologie clinique adulte, équipe d'Accueil 7453 CHELTER, CHU Estaing, Université Clermont Auvergne, Clermont-Ferrand, France

Barbara Eichhorst, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Rifaldy Fajar, IMCDS-BioMed Research Foundation, IMCDS-BioMed Research Foundation, Jakarta, Indonesia

Kirsten Fischer, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Johannes Förner, German Cancer Research Center (DKFZ), Patient Advisory Council for Cancer Research, Heidelberg

Moritz Fürstenau, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Paolo Ghia, MD Medical Oncology, Università Vita-Salute San Raffaele di Milano, Italy

Valentin Goede, MD Department of Oncogeriatrics, St. Marien Hospital, Cologne, Germany

Ellinor Görgen, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Rosalie R. Griffin, PhD University of Texas, MD Anderson Cancer Center, Houston, United States

Michael Hallek, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Paul J. Hampel, MD Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, United States

Kamrul Hasan, PhD University of California San Diego, La Jolla, United Staes

Anna Herr, Department of Medicine III, School of Medicine and Health, Technical University of Munich, Munich, Germany

Manuela Hoechstetter, MD Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany

Jennifer Y. Huang, MD Fred Hutchinson Cancer Center, Seattle, WA, USA; University of Washington, Seattle, United States

Henriette Huber, MD Medical Clinic III, Municipal Hospital Karlsruhe, Karlsruhe, Germany

Thomas Illmer, MD Onkologie Dresden, Dresden, Germany

Christina Karamanidou, MD Institute of Applied Biosciences, Centre for Research & Technology-Hellas, Thessaloniki, Greece

Arnon P. Kater, MD, PhD Lymphoma and Myeloma Center, Academic Medical Center Amsterdam, University of Amsterdam, Amsterdam, The Netherlands

Sabina Kersting, MD Department of Hematology, HagaZiekenhuis, Den Haag, The Netherlands

Vanessa Klapp, Luxembourg Institute of Health, Cancer Research, Luxembourg, Luxembourg

Manuel Knauer, MD Department of Medicine III, School of Medicine and Health, Technical University of Munich, Munich, Germany

Nadine Kutsch, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Marwan Kwok, PhD Centre for Clinical Haematology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom

Petra Langerbeins, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Richard Lewis, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Viviana Lipinsky, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Paolo Lopedote, MD City of Hope National Medical Center, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, United States

Carlota Lopez-Sanchez, Department of Hematology, University of Amsterdam, Amsterdam, The Netherlands

Ben M. Mechtel, Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Riccardo Moia, MD Università del Piemonte Orientale, Division of Hematology, Department of Translational Medicine, Novara, Italy

Talha Munir, MD Department of Haematology, St. James's University Hospital, Leeds, United Kingdome

Carsten U. Niemann, MD Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Thomas Oellerich, MD Department of Hematology/Medical Oncology, University Hospital Frankfurt, Germany

Susan O`Brien, MD Division of Hematology/Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, United States

Fleur S. Peters, PhD Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

Alan Ramsay, MD Department of Cellular Pathology, University College London Hospitals NHS Foundation Trust, London, United Kingdome

Andrew Rawstron, MD Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Matthias Ritgen, MD Universitätsklinik Schleswig-Holstein, Kiel, Germany

Davide Rossi, MD, PhD Hospital San Giovanni, Bellinzona, Switzerland

Lydia Scarfò, MD Strategic Research Program on Chronic Lymphocytic Leukemia, IRCCS Ospedale San Raffaele, Milano, Italy; Università Vita Salute San Raffaele, Milano, Italy

Anna Schuh, MD Department of Oncology, Oxford Molecular Diagnostics Centre, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

Florian Simon, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Philipp B. Staber, MD, PhD Department of Hematology and Hemostosiology, University Hospital Vienna, Austria

Stephan Stilgenbauer, MD Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany

Janina Stumpf, MD Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany

Tamar Tadmor, MD Hematology Unit, Bnai-Zion Medical Center, Haifa, Israel

Eugen Tausch, MD Division of CLL, Department of Internal Medicine III, University of Ulm, Ulm, Germany

Allessandra Tedeschi, MD Department of Hematology, Azienda Socio Sanitaria Territoriali Grande Ospedale Metropolitano Niguarda, Milan, Italy

Elisa ten Hacken, PhD Department of Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York City, NY, United States

Chiara Tomasoni, PhD Weil Cornell Medical College, New York City, United States

William G. Wierda, MD Department of Leukemia, Devision of Cancer Medicine, MD Anderson Cancer Center, University of Texas, Houston, United States

Xiancheng Wu, MD University of Washington/Fred Hutchinson Cancer Center, Hematology and Medical Oncology, Seattle, United States

René Zahedi, PhD Manitoba Centre for Proteomics and Systems Biology, University of Manitoba, Winnipeg, Canada